跳至主要内容
临床试验/NCT01142999
NCT01142999Unknown不适用

Feasibility Study of Barrier Enhancement for Eczema Prevention (BEEP)

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2010年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
46
试验地点
1
主要终点
Proportion of families willing to be randomized.

研究概览

简要总结

The purpose of this protocol is to determine the feasibility of doing larger follow-up studies examining whether emollients used from birth can prevent eczema in high-risk babies and to help investigators find out if emollients (moisturizing skin creams) used from birth can prevent eczema in high-risk babies. Hypothesis: Enhancing the skin barrier from birth using emollients will prevent or delay the onset of eczema, especially in predisposed infants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
1 Minute 至 6 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Participant must have a parent or sibling with a history of at least one of the following: eczema, allergic rhinitis or asthma
  • Infant in overall good health
  • Mother between the ages of 16 and 45 years of age at delivery; infant from birth thru 6 months of age
  • Capable of giving informed consent

排除标准

  • Preterm birth defined as birth prior to 37 weeks gestation
  • Major congenital anomaly
  • Hydrops fetalis
  • Significant dermatitis at birth not including seborrheic dermatitis ("cradle cap")
  • Any immunodeficiency disorder or severe genetic skin disorder
  • Any other serious condition that would make the use of emollients inadvisable
  • Any other major medical problems that the investigator deems may increase the risk of adverse events with the intervention

研究组 & 干预措施

Intervention (moisturizer group)

Active Comparator

One group will be instructed to use a choice of 3 FDA-approved moisturizers and soap substitutes on their newborn infants.

干预措施: Sunflower oil (Drug)

Intervention (moisturizer group)

Active Comparator

One group will be instructed to use a choice of 3 FDA-approved moisturizers and soap substitutes on their newborn infants.

干预措施: Aquaphor ointment (Drug)

Intervention (moisturizer group)

Active Comparator

One group will be instructed to use a choice of 3 FDA-approved moisturizers and soap substitutes on their newborn infants.

干预措施: Cetaphil cream (Drug)

Control group (no moisturizers)

Active Comparator

This group will be asked NOT to use any skin moisturizers and use only soap substitutes on their infants.

干预措施: Control group (Drug)

结局指标

主要结局

Proportion of families willing to be randomized.

时间窗: 6 months

Determine proportion of families willing to be randomized in order to design larger study in the future.

次要结局

  • Proportion of families eligible for the trial, willing to participate(6 months)
  • Proportion of families who found the interventions acceptable(6 months)
  • Reported adherence with intervention(6 months)
  • Proportion of families for whom the blinding of the assessor to the allocation ostatus was not compromised(6 months)
  • Amount of contamination as a result of increased awareness in the control group(6 months)
  • Percentage of missing data and early withdrawal rates(6 months)
  • Incidence of emollient-related adverse events(6 months)
  • Incidence of eczema at 6 and 12 months(12 months)
  • Age at onset of eczema(6 months)
  • Filaggrin mutation status(6 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Feasibility Study of Barrier Enhancement for Eczema... | 临床试验